Sat Kartar Life, a company in the Pharmaceuticals industry, reported revenue of ₹106 crore and net profit of ₹9.00 crore for the September 2026 quarter.
Sat Kartar Life (NSE: SATKARTAR-SM) closed at ₹150.00 on 20 Nov 2026. Its market capitalisation is ₹237 crore and it trades at 12.5 times earnings.
Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company that delivers natural wellness solutions for therapeutic and lifestyle products.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.